Faculty Appointments
Professor of Medicine
Education
M.D., Case Western Reserve University, Cleveland, OhioB.A., Brown University, Providence, Rhode Island
Office Address
T-1217 MCN
TN 2650
TN 2650
Publications
Hemnes AR, Rathinasabapathy A, Austin EA, Brittain EL, Carrier EJ, Chen X, Fessel JP, Fike CD, Fong P, Fortune N, Gerszten RE, Johnson JA, Kaplowitz M, Newman JH, Piana R, Pugh ME, Rice TW, Robbins IM, Wheeler L, Yu C, Loyd JE, West J. A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension. Eur. Respir. J [electronic-print]. 2018 Jun; 51(6): PMID: 29903860, PII: 13993003.02638-2017, DOI: 10.1183/13993003.02638-2017, ISSN: 1399-3003.
Meoli DF, Su YR, Brittain EL, Robbins IM, Hemnes AR, Monahan K. The transpulmonary ratio of endothelin 1 is elevated in patients with preserved left ventricular ejection fraction and combined pre- and post-capillary pulmonary hypertension. Pulm Circ [print-electronic]. 2018 Jan; 8(1): 2045893217745019. PMID: 29251543, PMCID: PMC5764145, DOI: 10.1177/2045893217745019, ISSN: 2045-8932.
Assad TR, Maron BA, Robbins IM, Xu M, Huang S, Harrell FE, Farber-Eger EH, Wells QS, Choudhary G, Hemnes AR, Brittain EL. Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension. JAMA Cardiol. 2017 Dec 12/1/2017; 2(12): 1361-8. PMID: 29071338, PMCID: PMC5814998, PII: 2659488, DOI: 10.1001/jamacardio.2017.3882, ISSN: 2380-6591.
Welch CE, Brittain EL, Newman AL, Robbins IM, Pugh ME, Newman JH, Hemnes AR. End-Tidal Carbon Dioxide as a Prognostic Feature in Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2017 Jun; 14(6): 896-902. PMID: 28345964, DOI: 10.1513/AnnalsATS.201612-951OC, ISSN: 2325-6621.
Robbins IM, Pugh ME, Hemnes AR. Update on chronic thromboembolic pulmonary hypertension. Trends Cardiovasc. Med [print-electronic]. 2017 Jan; 27(1): 29-37. PMID: 27345156, PII: S1050-1738(16)30054-8, DOI: 10.1016/j.tcm.2016.05.010, ISSN: 1873-2615.
Assad TR, Brittain EL, Wells QS, Farber-Eger EH, Halliday SJ, Doss LN, Xu M, Wang L, Harrell FE, Yu C, Robbins IM, Newman JH, Hemnes AR. Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension. Pulm Circ. 2016 Sep; 6(3): 313-21. PMID: 27683608, PMCID: PMC5019084, PII: PC2013344, DOI: 10.1086/688516, ISSN: 2045-8932.
Matthews DT, Le CN, Robbins IM, Petracek MR, Pugh ME, Brittain EL, Hemnes AR. Severity of pulmonary hypertension and obesity are not associated with worse functional outcomes after pulmonary thromboendarterectomy. Pulm Circ. 2016 Jun; 6(2): 174-80. PMID: 27252843, PMCID: PMC4869921, PII: PC2013298, DOI: 10.1086/685736, ISSN: 2045-8932.
Mar PL, Nwazue V, Black BK, Biaggioni I, Diedrich A, Paranjape SY, Loyd JE, Hemnes AR, Robbins IM, Robertson D, Raj SR, Austin ED. Valsalva Maneuver in Pulmonary Arterial Hypertension: Susceptibility to Syncope and Autonomic Dysfunction. Chest [print-electronic]. 2016 May; 149(5): 1252-60. PMID: 26836906, PII: S0012-3692(15)00181-6, DOI: 10.1016/j.chest.2015.11.015, ISSN: 1931-3543.
Hay BR, Pugh ME, Robbins IM, Hemnes AR. Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study. Chest [print-electronic]. 2016 Mar; 149(3): 660-6. PMID: 26378379, PII: S0012-3692(15)00020-3, DOI: 10.1378/chest.15-1051, ISSN: 1931-3543.
Hemnes AR, Zhao M, West J, Newman JH, Rich S, Archer SL, Robbins IM, Blackwell TS, Cogan J, Loyd JE, Zhao Z, Gaskill C, Jetter C, Kropski JA, Majka SM, Austin ED. Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension. Am. J. Respir. Crit. Care Med [print-electronic]. 2016 Feb 2/29/2016; PMID: 26926454, DOI: 10.1164/rccm.201508-1678OC, ISSN: 1535-4970.
Lathen C, Zhang Y, Chow J, Singh M, Lin G, Nigam V, Ashraf YA, Yuan JX, Robbins IM, Thistlethwaite PA. Response to Letter Regarding Article, "The ERG-APLNR Axis Controls Pulmonary Venule Endothelial Proliferation in Pulmonary Veno-Occlusive Disease" [letter]. Circulation. 2015 Jul 7/14/2015; 132(2): e17. PMID: 26169652, PMCID: PMC4624330, PII: CIRCULATIONAHA.114.014783, DOI: 10.1161/CIRCULATIONAHA.114.014783, ISSN: 1524-4539.
Robbins IM, Johnson J, Petracek M, Lambright E, Bream P, Merantz S, Pugh ME, Hemnes AR. Translocation of Microspheres into the Pulmonary Artery after Bronchial Artery Injection. Am. J. Respir. Crit. Care Med. 2015 Jun 6/15/2015; 191(12): e28-9. PMID: 26075434, DOI: 10.1164/rccm.201412-2325IM, ISSN: 1535-4970.
Trammell AW, Pugh ME, Newman JH, Hemnes AR, Robbins IM. Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers. Pulm Circ. 2015 Jun; 5(2): 356-63. PMID: 26064462, PMCID: PMC4449248, PII: PC2013183, DOI: 10.1086/681264, ISSN: 2045-8932.
Newman JH, Brittain EL, Robbins IM, Hemnes AR. Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension. Chest. 2015 Apr; 147(4): 1080-5. PMID: 25340330, PMCID: PMC4388116, PII: S0012-3692(15)38957-1, DOI: 10.1378/chest.14-1461, ISSN: 1931-3543.
Halliday SJ, Hemnes AR, Robbins IM, Pugh ME, Zhao DX, Piana RN, Fong PP, Brittain EL. Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" responders. J. Heart Lung Transplant [print-electronic]. 2015 Mar; 34(3): 312-8. PMID: 25577565, PMCID: PMC4380573, PII: S1053-2498(14)01424-7, DOI: 10.1016/j.healun.2014.10.003, ISSN: 1557-3117.
Hemnes AR, Trammell AW, Archer SL, Rich S, Yu C, Nian H, Penner N, Funke M, Wheeler L, Robbins IM, Austin ED, Newman JH, West J. Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension. Circulation [print-electronic]. 2015 Jan 1/27/2015; 131(4): 401-9; discussion 409. PMID: 25361553, PMCID: PMC4308423, PII: CIRCULATIONAHA.114.013317, DOI: 10.1161/CIRCULATIONAHA.114.013317, ISSN: 1524-4539.
Pugh ME, Hemnes AR, Trammell A, Newman JH, Robbins IM. Variability in hemodynamic evaluation of pulmonary hypertension at large referral centers. Pulm Circ. 2014 Dec; 4(4): 679-84. PMID: 25610603, PMCID: PMC4278627, PII: PC2013117, DOI: 10.1086/678514, ISSN: 2045-8932.
Shaver CM, Castilho JL, Cohen DN, Grogan EL, Miller GG, Dummer JS, Gray JN, Lambright ES, Loyd JE, Robbins IM. Fatal Scopulariopsis infection in a lung transplant recipient: lessons of organ procurement. Am. J. Transplant [print-electronic]. 2014 Dec; 14(12): 2893-7. PMID: 25376207, PMCID: PMC4263480, DOI: 10.1111/ajt.12940, ISSN: 1600-6143.
Lathen C, Zhang Y, Chow J, Singh M, Lin G, Nigam V, Ashraf YA, Yuan JX, Robbins IM, Thistlethwaite PA. ERG-APLNR axis controls pulmonary venule endothelial proliferation in pulmonary veno-occlusive disease. Circulation [print-electronic]. 2014 Sep 9/30/2014; 130(14): 1179-91. PMID: 25062690, PMCID: PMC4182129, PII: CIRCULATIONAHA.113.007822, DOI: 10.1161/CIRCULATIONAHA.113.007822, ISSN: 1524-4539.
Pugh ME, Sivarajan L, Wang L, Robbins IM, Newman JH, Hemnes AR. Causes of pulmonary hypertension in the elderly. Chest. 2014 Jul; 146(1): 159-66. PMID: 24480915, PMCID: PMC4077408, PII: S0012-3692(15)48760-4, DOI: 10.1378/chest.13-1900, ISSN: 1931-3543.
Benson L, Brittain EL, Pugh ME, Austin ED, Fox K, Wheeler L, Robbins IM, Hemnes AR. Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension. Pulm Circ. 2014 Jun; 4(2): 311-8. PMID: 25006450, PMCID: PMC4070784, PII: PC2013057, DOI: 10.1086/675994, ISSN: 2045-8932.
Chin KM, Badesch DB, Robbins IM, Tapson VF, Palevsky HI, Kim NH, Kawut SM, Frost A, Benton WW, Lemarie JC, Bodin F, Rubin LJ, McLaughlin V. Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study. Am. Heart J [print-electronic]. 2014 Feb; 167(2): 218-225.e1. PMID: 24439983, PII: S0002-8703(13)00532-2, DOI: 10.1016/j.ahj.2013.08.008, ISSN: 1097-6744.
Best DH, Sumner KL, Austin ED, Chung WK, Brown LM, Borczuk AC, Rosenzweig EB, Bayrak-Toydemir P, Mao R, Cahill BC, Tazelaar HD, Leslie KO, Hemnes AR, Robbins IM, Elliott CG. EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Chest. 2014 Feb; 145(2): 231-6. PMID: 24135949, PMCID: PMC3921094, PII: S0012-3692(15)34162-3, DOI: 10.1378/chest.13-2366, ISSN: 1931-3543.
Robbins IM, Hemnes AR, Pugh ME, Brittain EL, Zhao DX, Piana RN, Fong PP, Newman JH. High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail [print-electronic]. 2014 Jan; 7(1): 116-22. PMID: 24297689, PMCID: PMC3934572, PII: CIRCHEARTFAILURE.113.000468, DOI: 10.1161/CIRCHEARTFAILURE.113.000468, ISSN: 1941-3297.
Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 2013 Dec 12/24/2013; 62(25 Suppl): D34-41. PMID: 24355639, PII: S0735-1097(13)05872-5, DOI: 10.1016/j.jacc.2013.10.029, ISSN: 1558-3597.
Pugh ME, Hemnes AR, Robbins IM. Combination therapy in pulmonary arterial hypertension. Clin. Chest Med [print-electronic]. 2013 Dec; 34(4): 841-55. PMID: 24267308, PII: S0272-5231(13)00107-X, DOI: 10.1016/j.ccm.2013.08.007, ISSN: 1557-8216.
Brittain EL, Pugh ME, Wheeler LA, Robbins IM, Loyd JE, Newman JH, Larkin EK, Austin ED, Hemnes AR. Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function. Pulm Circ [print-electronic]. 2013 Sep; 3(3): 589-98. PMID: 24618543, PMCID: PMC4070798, DOI: 10.1086/674326, ISSN: 2045-8932.
Brittain EL, Pugh ME, Wheeler LA, Robbins IM, Loyd JE, Newman JH, Austin ED, Hemnes AR. Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension. JACC Heart Fail. 2013 Aug; 1(4): 300-7. PMID: 24015376, PMCID: PMC3763862, PII: S2213-1779(13)00189-3, DOI: 10.1016/j.jchf.2013.05.004, ISSN: 2213-1787.
Monahan K, Scott TA, Su YR, Lenneman CG, Zhao DX, Robbins IM, Hemnes AR. Reproducibility of intracardiac and transpulmonary biomarkers in the evaluation of pulmonary hypertension. Pulm Circ. 2013 Apr; 3(2): 345-9. PMID: 24015334, PMCID: PMC3757828, PII: PC-3-345, DOI: 10.4103/2045-8932.114762, ISSN: 2045-8932.
Brittain EL, Pugh ME, Wang L, Newman AL, Robbins IM, Newman JH, Hemnes AR. Predictors of diastolic-to-wedge gradient in patients evaluated for pulmonary hypertension. PLoS ONE. 2013; 8(10): e76461. PMID: 24124561, PMCID: PMC3790694, PII: PONE-D-13-27489, DOI: 10.1371/journal.pone.0076461, ISSN: 1932-6203.
Pugh ME, Buchowski MS, Robbins IM, Newman JH, Hemnes AR. Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension. Chest. 2012 Dec; 142(6): 1391-8. PMID: 22576635, PMCID: PMC3515022, PII: chest.12-0150, DOI: 10.1378/chest.12-0150, ISSN: 1931-3543.
Larkin EK, Newman JH, Austin ED, Hemnes AR, Wheeler L, Robbins IM, West JD, Phillips JA, Hamid R, Loyd JE. Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med [print-electronic]. 2012 Nov 11/1/2012; 186(9): 892-6. PMID: 22923661, PMCID: PMC3530218, PII: rccm.201205-0886OC, DOI: 10.1164/rccm.201205-0886OC, ISSN: 1535-4970.
Robbins IM, Moore TM, Blaisdell CJ, Abman SH. National Heart, Lung, and Blood Institute Workshop: improving outcomes for pulmonary vascular disease. Circulation [print-electronic]. 2012 May 5/1/2012; 125(17): 2165-70. PMID: 22388326, PII: CIRCULATIONAHA.112.092924, DOI: 10.1161/CIRCULATIONAHA.112.092924, ISSN: 1524-4539.
Robbins IM, Moore TM, Blaisdell CJ, Abman SH. Improving outcomes for pulmonary vascular disease. Am. J. Respir. Crit. Care Med [print-electronic]. 2012 May 5/1/2012; 185(9): 1015-20. PMID: 22335936, PMCID: PMC3359939, PII: rccm.201201-0049WS, DOI: 10.1164/rccm.201201-0049WS, ISSN: 1535-4970.
Hemnes AR, Pugh ME, Newman AL, Robbins IM, Tolle J, Austin ED, Newman JH. End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment. Chest [print-electronic]. 2011 Nov; 140(5): 1267-73. PMID: 21622547, PII: chest.11-0155, DOI: 10.1378/chest.11-0155, ISSN: 1931-3543.
Pugh ME, Robbins IM, Rice TW, West J, Newman JH, Hemnes AR. Unrecognized glucose intolerance is common in pulmonary arterial hypertension. J. Heart Lung Transplant [print-electronic]. 2011 Aug; 30(8): 904-11. PMID: 21493097, PMCID: PMC3129440, PII: S1053-2498(11)00831-X, DOI: 10.1016/j.healun.2011.02.016, ISSN: 1557-3117.
Luo YF, Robbins IM, Karatas M, Brixey AG, Rice TW, Light RW. Frequency of pleural effusions in patients with pulmonary arterial hypertension associated with connective tissue diseases. Chest [print-electronic]. 2011 Jul; 140(1): 42-7. PMID: 21212140, PII: chest.10-0227, DOI: 10.1378/chest.10-0227, ISSN: 1931-3543.
Robbins IM, Hemnes AR, Gibbs JS, Christman BW, Howard L, Meehan S, Cabrita I, Gonzalez R, Oyler T, Zhao L, Du RH, Mendes LA, Wilkins MR. Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertension. Exp. Lung Res [print-electronic]. 2011 Feb; 37(1): 26-34. PMID: 21077779, DOI: 10.3109/01902148.2010.512972, ISSN: 1521-0499.
Austin ED, Rock MT, Mosse CA, Vnencak-Jones CL, Yoder SM, Robbins IM, Loyd JE, Meyrick BO. T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension. Respir Med [print-electronic]. 2010 Mar; 104(3): 454-62. PMID: 19880300, PMCID: PMC2826574, PII: S0954-6111(09)00325-4, DOI: 10.1016/j.rmed.2009.10.004, ISSN: 1532-3064.
Hemnes AR, Doyle TP, Janssen D, Robbins IM. Congenital pulmonary artery stenoses masquerading as chronic thromboembolic disease. J. Heart Lung Transplant. 2009 Oct; 28(10): 1110-1. PMID: 19782296, PMCID: PMC2757639, PII: S1053-2498(09)00485-9, DOI: 10.1016/j.healun.2009.06.014, ISSN: 1557-3117.
Tang KJ, Robbins IM, Light RW. Incidence of pleural effusions in idiopathic and familial pulmonary arterial hypertension patients. Chest [print-electronic]. 2009 Sep; 136(3): 688-93. PMID: 19395582, PII: chest.08-0659, DOI: 10.1378/chest.08-0659, ISSN: 1931-3543.
Robbins IM, Newman JH, Johnson RF, Hemnes AR, Fremont RD, Piana RN, Zhao DX, Byrne DW. Association of the metabolic syndrome with pulmonary venous hypertension. Chest [print-electronic]. 2009 Jul; 136(1): 31-6. PMID: 19188551, PMCID: PMC2716716, PII: chest.08-2008, DOI: 10.1378/chest.08-2008, ISSN: 1931-3543.
Austin ED, Phillips JA, Cogan JD, Hamid R, Yu C, Stanton KC, Phillips CA, Wheeler LA, Robbins IM, Newman JH, Loyd JE. Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension. Respir. Res. 2009; 10: 87. PMID: 19785764, PMCID: PMC2762975, PII: 1465-9921-10-87, DOI: 10.1186/1465-9921-10-87, ISSN: 1465-993X.
Hemnes AR, Robbins IM. Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation. Liver Transpl. 2009 Jan; 15(1): 15-9. PMID: 19109843, PMCID: PMC3804427, DOI: 10.1002/lt.21479, ISSN: 1527-6473.
Johnson RF, Loyd JE, Mullican AL, Fink CA, Robbins IM. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension. J. Heart Lung Transplant [print-electronic]. 2007 Apr; 26(4): 363-9. PMID: 17403478, PII: S1053-2498(07)00041-1, DOI: 10.1016/j.healun.2007.01.022, ISSN: 1557-3117.
Cogan JD, Pauciulo MW, Batchman AP, Prince MA, Robbins IM, Hedges LK, Stanton KC, Wheeler LA, Phillips JA, Loyd JE, Nichols WC. High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med [print-electronic]. 2006 Sep 9/1/2006; 174(5): 590-8. PMID: 16728714, PMCID: PMC2648061, PII: 200602-165OC, DOI: 10.1164/rccm.200602-165OC, ISSN: 1073-449X.
Willers ED, Newman JH, Loyd JE, Robbins IM, Wheeler LA, Prince MA, Stanton KC, Cogan JA, Runo JR, Byrne D, Humbert M, Simonneau G, Sztrymf B, Morse JA, Knowles JA, Roberts KE, McElroy JJ, Barst RJ, Phillips JA. Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med [print-electronic]. 2006 Apr 4/1/2006; 173(7): 798-802. PMID: 16339917, PMCID: PMC2662954, PII: 200509-1361OC, DOI: 10.1164/rccm.200509-1361OC, ISSN: 1073-449X.
Robbins IM, Kawut SM, Yung D, Reilly MP, Lloyd W, Cunningham G, Loscalzo J, Kimmel SE, Christman BW, Barst RJ. A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension. Eur. Respir. J. 2006 Mar; 27(3): 578-84. PMID: 16507859, PII: 27/3/578, DOI: 10.1183/09031936.06.00095705, ISSN: 0903-1936.
Cogan JD, Vnencak-Jones CL, Phillips JA, Lane KB, Wheeler LA, Robbins IM, Garrison G, Hedges LK, Loyd JE. Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension. Genet. Med. 2005 Mar; 7(3): 169-74. PMID: 15775752, PII: 00125817-200503000-00003, DOI: 10.109701.GIM.0000156525.09595.E9, ISSN: 1098-3600.
Robbins IM, Morrow JD, Christman BW. Oxidant stress but not thromboxane decreases with epoprostenol therapy. Free Radic. Biol. Med. 2005 Mar 3/1/2005; 38(5): 568-74. PMID: 15683712, PII: S0891-5849(04)00965-7, DOI: 10.1016/j.freeradbiomed.2004.11.033, ISSN: 0891-5849.
Kuhn KP, Wickersham NE, Robbins IM, Byrne DW. Acute effects of sildenafil in patients with primary pulmonary hypertension receiving epoprostenol. Exp. Lung Res. 2004 Mar; 30(2): 135-45. PMID: 14972773, PII: J2WM7MFN21M0V50L, ISSN: 0190-2148.
Runo JR, Welch DC, Ness EM, Robbins IM, Milstone AP. Miliary tuberculosis as a cause of acute empyema. Respiration. 2003 Sep; 70(5): 529-32. PMID: 14665781, PII: 74213, DOI: 74213, ISSN: 0025-7931.
Runo JR, Vnencak-Jones CL, Prince M, Loyd JE, Wheeler L, Robbins IM, Lane KB, Newman JH, Johnson J, Nichols WC, Phillips JA. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Am. J. Respir. Crit. Care Med [print-electronic]. 2003 Mar 3/15/2003; 167(6): 889-94. PMID: 12446270, PII: 200208-861OC, DOI: 10.1164/rccm.200208-861OC, ISSN: 1073-449X.
Kuhn KP, Byrne DW, Arbogast PG, Doyle TP, Loyd JE, Robbins IM. Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol. Am. J. Respir. Crit. Care Med [print-electronic]. 2003 Feb 2/15/2003; 167(4): 580-6. PMID: 12446266, PII: 200204-333OC, DOI: 10.1164/rccm.200204-333OC, ISSN: 1073-449X.
Robbins IM, Barst RJ, Rubin LJ, Gaine SP, Price PV, Morrow JD, Christman BW. Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension. Chest. 2001 Nov; 120(5): 1639-44. PMID: 11713147, PII: S0012-3692(15)36373-X, ISSN: 0012-3692.
Doyle TP, Loyd JE, Robbins IM. Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis. Am. J. Respir. Crit. Care Med. 2001 Aug 8/15/2001; 164(4): 657-60. PMID: 11520733, DOI: 10.1164/ajrccm.164.4.2012132, ISSN: 1073-449X.
Holcomb BW, Loyd JE, Byrd BF, Wilsdorf TT, Casey-Cato T, Mason WR, Robbins IM. Iatrogenic paradoxical air embolism in pulmonary hypertension. Chest. 2001 May; 119(5): 1602-5. PMID: 11348976, PII: S0012-3692(15)39629-X, ISSN: 0012-3692.
Holcomb BW, Loyd JE, Ely EW, Johnson J, Robbins IM. Pulmonary veno-occlusive disease: a case series and new observations. Chest. 2000 Dec; 118(6): 1671-9. PMID: 11115457, PII: S0012-3692(15)37877-6, ISSN: 0012-3692.
Sadikot RT, Robbins IM. An interesting electrolyte problem. Postgrad Med J. 2000 Jul; 76(897): 435, 447-8. PMID: 10878216, PMCID: PMC1741634, ISSN: 0032-5473.
Robbins IM, Gaine SP, Schilz R, Tapson VF, Rubin LJ, Loyd JE. Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus. Chest. 2000 Jan; 117(1): 14-8. PMID: 10631192, PII: S0012-3692(15)30922-3, ISSN: 0012-3692.
Robbins IM, Christman BW, Newman JH, Matlock R, Loyd JE. A survey of diagnostic practices and the use of epoprostenol in patients with primary pulmonary hypertension. Chest. 1998 Nov; 114(5): 1269-75. PMID: 9824000, PII: S0012-3692(16)33059-8, ISSN: 0012-3692.
Robbins IM, Colvin EV, Doyle TP, Kemp WE, Loyd JE, McMahon WS, Kay GN. Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation. 1998 Oct 10/27/1998; 98(17): 1769-75. PMID: 9788832, ISSN: 0009-7322.
Robbins IM, Cuiper LL, Stein CM, Wood AJ, He HB, Parker R, Christman BW. Angiotensin II mediates systemic rebound hypertension after cessation of prostacyclin infusion in sheep. J. Appl. Physiol. 1998 Aug; 85(2): 731-7. PMID: 9688753, ISSN: 8750-7587.
Meoli DF, Su YR, Brittain EL, Robbins IM, Hemnes AR, Monahan K. The transpulmonary ratio of endothelin 1 is elevated in patients with preserved left ventricular ejection fraction and combined pre- and post-capillary pulmonary hypertension. Pulm Circ [print-electronic]. 2018 Jan; 8(1): 2045893217745019. PMID: 29251543, PMCID: PMC5764145, DOI: 10.1177/2045893217745019, ISSN: 2045-8932.
Assad TR, Maron BA, Robbins IM, Xu M, Huang S, Harrell FE, Farber-Eger EH, Wells QS, Choudhary G, Hemnes AR, Brittain EL. Prognostic Effect and Longitudinal Hemodynamic Assessment of Borderline Pulmonary Hypertension. JAMA Cardiol. 2017 Dec 12/1/2017; 2(12): 1361-8. PMID: 29071338, PMCID: PMC5814998, PII: 2659488, DOI: 10.1001/jamacardio.2017.3882, ISSN: 2380-6591.
Welch CE, Brittain EL, Newman AL, Robbins IM, Pugh ME, Newman JH, Hemnes AR. End-Tidal Carbon Dioxide as a Prognostic Feature in Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2017 Jun; 14(6): 896-902. PMID: 28345964, DOI: 10.1513/AnnalsATS.201612-951OC, ISSN: 2325-6621.
Robbins IM, Pugh ME, Hemnes AR. Update on chronic thromboembolic pulmonary hypertension. Trends Cardiovasc. Med [print-electronic]. 2017 Jan; 27(1): 29-37. PMID: 27345156, PII: S1050-1738(16)30054-8, DOI: 10.1016/j.tcm.2016.05.010, ISSN: 1873-2615.
Assad TR, Brittain EL, Wells QS, Farber-Eger EH, Halliday SJ, Doss LN, Xu M, Wang L, Harrell FE, Yu C, Robbins IM, Newman JH, Hemnes AR. Hemodynamic evidence of vascular remodeling in combined post- and precapillary pulmonary hypertension. Pulm Circ. 2016 Sep; 6(3): 313-21. PMID: 27683608, PMCID: PMC5019084, PII: PC2013344, DOI: 10.1086/688516, ISSN: 2045-8932.
Matthews DT, Le CN, Robbins IM, Petracek MR, Pugh ME, Brittain EL, Hemnes AR. Severity of pulmonary hypertension and obesity are not associated with worse functional outcomes after pulmonary thromboendarterectomy. Pulm Circ. 2016 Jun; 6(2): 174-80. PMID: 27252843, PMCID: PMC4869921, PII: PC2013298, DOI: 10.1086/685736, ISSN: 2045-8932.
Mar PL, Nwazue V, Black BK, Biaggioni I, Diedrich A, Paranjape SY, Loyd JE, Hemnes AR, Robbins IM, Robertson D, Raj SR, Austin ED. Valsalva Maneuver in Pulmonary Arterial Hypertension: Susceptibility to Syncope and Autonomic Dysfunction. Chest [print-electronic]. 2016 May; 149(5): 1252-60. PMID: 26836906, PII: S0012-3692(15)00181-6, DOI: 10.1016/j.chest.2015.11.015, ISSN: 1931-3543.
Hay BR, Pugh ME, Robbins IM, Hemnes AR. Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study. Chest [print-electronic]. 2016 Mar; 149(3): 660-6. PMID: 26378379, PII: S0012-3692(15)00020-3, DOI: 10.1378/chest.15-1051, ISSN: 1931-3543.
Hemnes AR, Zhao M, West J, Newman JH, Rich S, Archer SL, Robbins IM, Blackwell TS, Cogan J, Loyd JE, Zhao Z, Gaskill C, Jetter C, Kropski JA, Majka SM, Austin ED. Critical Genomic Networks and Vasoreactive Variants in Idiopathic Pulmonary Arterial Hypertension. Am. J. Respir. Crit. Care Med [print-electronic]. 2016 Feb 2/29/2016; PMID: 26926454, DOI: 10.1164/rccm.201508-1678OC, ISSN: 1535-4970.
Lathen C, Zhang Y, Chow J, Singh M, Lin G, Nigam V, Ashraf YA, Yuan JX, Robbins IM, Thistlethwaite PA. Response to Letter Regarding Article, "The ERG-APLNR Axis Controls Pulmonary Venule Endothelial Proliferation in Pulmonary Veno-Occlusive Disease" [letter]. Circulation. 2015 Jul 7/14/2015; 132(2): e17. PMID: 26169652, PMCID: PMC4624330, PII: CIRCULATIONAHA.114.014783, DOI: 10.1161/CIRCULATIONAHA.114.014783, ISSN: 1524-4539.
Robbins IM, Johnson J, Petracek M, Lambright E, Bream P, Merantz S, Pugh ME, Hemnes AR. Translocation of Microspheres into the Pulmonary Artery after Bronchial Artery Injection. Am. J. Respir. Crit. Care Med. 2015 Jun 6/15/2015; 191(12): e28-9. PMID: 26075434, DOI: 10.1164/rccm.201412-2325IM, ISSN: 1535-4970.
Trammell AW, Pugh ME, Newman JH, Hemnes AR, Robbins IM. Use of pulmonary arterial hypertension-approved therapy in the treatment of non-group 1 pulmonary hypertension at US referral centers. Pulm Circ. 2015 Jun; 5(2): 356-63. PMID: 26064462, PMCID: PMC4449248, PII: PC2013183, DOI: 10.1086/681264, ISSN: 2045-8932.
Newman JH, Brittain EL, Robbins IM, Hemnes AR. Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension. Chest. 2015 Apr; 147(4): 1080-5. PMID: 25340330, PMCID: PMC4388116, PII: S0012-3692(15)38957-1, DOI: 10.1378/chest.14-1461, ISSN: 1931-3543.
Halliday SJ, Hemnes AR, Robbins IM, Pugh ME, Zhao DX, Piana RN, Fong PP, Brittain EL. Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" responders. J. Heart Lung Transplant [print-electronic]. 2015 Mar; 34(3): 312-8. PMID: 25577565, PMCID: PMC4380573, PII: S1053-2498(14)01424-7, DOI: 10.1016/j.healun.2014.10.003, ISSN: 1557-3117.
Hemnes AR, Trammell AW, Archer SL, Rich S, Yu C, Nian H, Penner N, Funke M, Wheeler L, Robbins IM, Austin ED, Newman JH, West J. Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension. Circulation [print-electronic]. 2015 Jan 1/27/2015; 131(4): 401-9; discussion 409. PMID: 25361553, PMCID: PMC4308423, PII: CIRCULATIONAHA.114.013317, DOI: 10.1161/CIRCULATIONAHA.114.013317, ISSN: 1524-4539.
Pugh ME, Hemnes AR, Trammell A, Newman JH, Robbins IM. Variability in hemodynamic evaluation of pulmonary hypertension at large referral centers. Pulm Circ. 2014 Dec; 4(4): 679-84. PMID: 25610603, PMCID: PMC4278627, PII: PC2013117, DOI: 10.1086/678514, ISSN: 2045-8932.
Shaver CM, Castilho JL, Cohen DN, Grogan EL, Miller GG, Dummer JS, Gray JN, Lambright ES, Loyd JE, Robbins IM. Fatal Scopulariopsis infection in a lung transplant recipient: lessons of organ procurement. Am. J. Transplant [print-electronic]. 2014 Dec; 14(12): 2893-7. PMID: 25376207, PMCID: PMC4263480, DOI: 10.1111/ajt.12940, ISSN: 1600-6143.
Lathen C, Zhang Y, Chow J, Singh M, Lin G, Nigam V, Ashraf YA, Yuan JX, Robbins IM, Thistlethwaite PA. ERG-APLNR axis controls pulmonary venule endothelial proliferation in pulmonary veno-occlusive disease. Circulation [print-electronic]. 2014 Sep 9/30/2014; 130(14): 1179-91. PMID: 25062690, PMCID: PMC4182129, PII: CIRCULATIONAHA.113.007822, DOI: 10.1161/CIRCULATIONAHA.113.007822, ISSN: 1524-4539.
Pugh ME, Sivarajan L, Wang L, Robbins IM, Newman JH, Hemnes AR. Causes of pulmonary hypertension in the elderly. Chest. 2014 Jul; 146(1): 159-66. PMID: 24480915, PMCID: PMC4077408, PII: S0012-3692(15)48760-4, DOI: 10.1378/chest.13-1900, ISSN: 1931-3543.
Benson L, Brittain EL, Pugh ME, Austin ED, Fox K, Wheeler L, Robbins IM, Hemnes AR. Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertension. Pulm Circ. 2014 Jun; 4(2): 311-8. PMID: 25006450, PMCID: PMC4070784, PII: PC2013057, DOI: 10.1086/675994, ISSN: 2045-8932.
Chin KM, Badesch DB, Robbins IM, Tapson VF, Palevsky HI, Kim NH, Kawut SM, Frost A, Benton WW, Lemarie JC, Bodin F, Rubin LJ, McLaughlin V. Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized study. Am. Heart J [print-electronic]. 2014 Feb; 167(2): 218-225.e1. PMID: 24439983, PII: S0002-8703(13)00532-2, DOI: 10.1016/j.ahj.2013.08.008, ISSN: 1097-6744.
Best DH, Sumner KL, Austin ED, Chung WK, Brown LM, Borczuk AC, Rosenzweig EB, Bayrak-Toydemir P, Mao R, Cahill BC, Tazelaar HD, Leslie KO, Hemnes AR, Robbins IM, Elliott CG. EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Chest. 2014 Feb; 145(2): 231-6. PMID: 24135949, PMCID: PMC3921094, PII: S0012-3692(15)34162-3, DOI: 10.1378/chest.13-2366, ISSN: 1931-3543.
Robbins IM, Hemnes AR, Pugh ME, Brittain EL, Zhao DX, Piana RN, Fong PP, Newman JH. High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail [print-electronic]. 2014 Jan; 7(1): 116-22. PMID: 24297689, PMCID: PMC3934572, PII: CIRCHEARTFAILURE.113.000468, DOI: 10.1161/CIRCHEARTFAILURE.113.000468, ISSN: 1941-3297.
Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 2013 Dec 12/24/2013; 62(25 Suppl): D34-41. PMID: 24355639, PII: S0735-1097(13)05872-5, DOI: 10.1016/j.jacc.2013.10.029, ISSN: 1558-3597.
Pugh ME, Hemnes AR, Robbins IM. Combination therapy in pulmonary arterial hypertension. Clin. Chest Med [print-electronic]. 2013 Dec; 34(4): 841-55. PMID: 24267308, PII: S0272-5231(13)00107-X, DOI: 10.1016/j.ccm.2013.08.007, ISSN: 1557-8216.
Brittain EL, Pugh ME, Wheeler LA, Robbins IM, Loyd JE, Newman JH, Larkin EK, Austin ED, Hemnes AR. Shorter survival in familial versus idiopathic pulmonary arterial hypertension is associated with hemodynamic markers of impaired right ventricular function. Pulm Circ [print-electronic]. 2013 Sep; 3(3): 589-98. PMID: 24618543, PMCID: PMC4070798, DOI: 10.1086/674326, ISSN: 2045-8932.
Brittain EL, Pugh ME, Wheeler LA, Robbins IM, Loyd JE, Newman JH, Austin ED, Hemnes AR. Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension. JACC Heart Fail. 2013 Aug; 1(4): 300-7. PMID: 24015376, PMCID: PMC3763862, PII: S2213-1779(13)00189-3, DOI: 10.1016/j.jchf.2013.05.004, ISSN: 2213-1787.
Monahan K, Scott TA, Su YR, Lenneman CG, Zhao DX, Robbins IM, Hemnes AR. Reproducibility of intracardiac and transpulmonary biomarkers in the evaluation of pulmonary hypertension. Pulm Circ. 2013 Apr; 3(2): 345-9. PMID: 24015334, PMCID: PMC3757828, PII: PC-3-345, DOI: 10.4103/2045-8932.114762, ISSN: 2045-8932.
Brittain EL, Pugh ME, Wang L, Newman AL, Robbins IM, Newman JH, Hemnes AR. Predictors of diastolic-to-wedge gradient in patients evaluated for pulmonary hypertension. PLoS ONE. 2013; 8(10): e76461. PMID: 24124561, PMCID: PMC3790694, PII: PONE-D-13-27489, DOI: 10.1371/journal.pone.0076461, ISSN: 1932-6203.
Pugh ME, Buchowski MS, Robbins IM, Newman JH, Hemnes AR. Physical activity limitation as measured by accelerometry in pulmonary arterial hypertension. Chest. 2012 Dec; 142(6): 1391-8. PMID: 22576635, PMCID: PMC3515022, PII: chest.12-0150, DOI: 10.1378/chest.12-0150, ISSN: 1931-3543.
Larkin EK, Newman JH, Austin ED, Hemnes AR, Wheeler L, Robbins IM, West JD, Phillips JA, Hamid R, Loyd JE. Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med [print-electronic]. 2012 Nov 11/1/2012; 186(9): 892-6. PMID: 22923661, PMCID: PMC3530218, PII: rccm.201205-0886OC, DOI: 10.1164/rccm.201205-0886OC, ISSN: 1535-4970.
Robbins IM, Moore TM, Blaisdell CJ, Abman SH. National Heart, Lung, and Blood Institute Workshop: improving outcomes for pulmonary vascular disease. Circulation [print-electronic]. 2012 May 5/1/2012; 125(17): 2165-70. PMID: 22388326, PII: CIRCULATIONAHA.112.092924, DOI: 10.1161/CIRCULATIONAHA.112.092924, ISSN: 1524-4539.
Robbins IM, Moore TM, Blaisdell CJ, Abman SH. Improving outcomes for pulmonary vascular disease. Am. J. Respir. Crit. Care Med [print-electronic]. 2012 May 5/1/2012; 185(9): 1015-20. PMID: 22335936, PMCID: PMC3359939, PII: rccm.201201-0049WS, DOI: 10.1164/rccm.201201-0049WS, ISSN: 1535-4970.
Hemnes AR, Pugh ME, Newman AL, Robbins IM, Tolle J, Austin ED, Newman JH. End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatment. Chest [print-electronic]. 2011 Nov; 140(5): 1267-73. PMID: 21622547, PII: chest.11-0155, DOI: 10.1378/chest.11-0155, ISSN: 1931-3543.
Pugh ME, Robbins IM, Rice TW, West J, Newman JH, Hemnes AR. Unrecognized glucose intolerance is common in pulmonary arterial hypertension. J. Heart Lung Transplant [print-electronic]. 2011 Aug; 30(8): 904-11. PMID: 21493097, PMCID: PMC3129440, PII: S1053-2498(11)00831-X, DOI: 10.1016/j.healun.2011.02.016, ISSN: 1557-3117.
Luo YF, Robbins IM, Karatas M, Brixey AG, Rice TW, Light RW. Frequency of pleural effusions in patients with pulmonary arterial hypertension associated with connective tissue diseases. Chest [print-electronic]. 2011 Jul; 140(1): 42-7. PMID: 21212140, PII: chest.10-0227, DOI: 10.1378/chest.10-0227, ISSN: 1931-3543.
Robbins IM, Hemnes AR, Gibbs JS, Christman BW, Howard L, Meehan S, Cabrita I, Gonzalez R, Oyler T, Zhao L, Du RH, Mendes LA, Wilkins MR. Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertension. Exp. Lung Res [print-electronic]. 2011 Feb; 37(1): 26-34. PMID: 21077779, DOI: 10.3109/01902148.2010.512972, ISSN: 1521-0499.
Austin ED, Rock MT, Mosse CA, Vnencak-Jones CL, Yoder SM, Robbins IM, Loyd JE, Meyrick BO. T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension. Respir Med [print-electronic]. 2010 Mar; 104(3): 454-62. PMID: 19880300, PMCID: PMC2826574, PII: S0954-6111(09)00325-4, DOI: 10.1016/j.rmed.2009.10.004, ISSN: 1532-3064.
Hemnes AR, Doyle TP, Janssen D, Robbins IM. Congenital pulmonary artery stenoses masquerading as chronic thromboembolic disease. J. Heart Lung Transplant. 2009 Oct; 28(10): 1110-1. PMID: 19782296, PMCID: PMC2757639, PII: S1053-2498(09)00485-9, DOI: 10.1016/j.healun.2009.06.014, ISSN: 1557-3117.
Tang KJ, Robbins IM, Light RW. Incidence of pleural effusions in idiopathic and familial pulmonary arterial hypertension patients. Chest [print-electronic]. 2009 Sep; 136(3): 688-93. PMID: 19395582, PII: chest.08-0659, DOI: 10.1378/chest.08-0659, ISSN: 1931-3543.
Robbins IM, Newman JH, Johnson RF, Hemnes AR, Fremont RD, Piana RN, Zhao DX, Byrne DW. Association of the metabolic syndrome with pulmonary venous hypertension. Chest [print-electronic]. 2009 Jul; 136(1): 31-6. PMID: 19188551, PMCID: PMC2716716, PII: chest.08-2008, DOI: 10.1378/chest.08-2008, ISSN: 1931-3543.
Austin ED, Phillips JA, Cogan JD, Hamid R, Yu C, Stanton KC, Phillips CA, Wheeler LA, Robbins IM, Newman JH, Loyd JE. Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension. Respir. Res. 2009; 10: 87. PMID: 19785764, PMCID: PMC2762975, PII: 1465-9921-10-87, DOI: 10.1186/1465-9921-10-87, ISSN: 1465-993X.
Hemnes AR, Robbins IM. Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation. Liver Transpl. 2009 Jan; 15(1): 15-9. PMID: 19109843, PMCID: PMC3804427, DOI: 10.1002/lt.21479, ISSN: 1527-6473.
Johnson RF, Loyd JE, Mullican AL, Fink CA, Robbins IM. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension. J. Heart Lung Transplant [print-electronic]. 2007 Apr; 26(4): 363-9. PMID: 17403478, PII: S1053-2498(07)00041-1, DOI: 10.1016/j.healun.2007.01.022, ISSN: 1557-3117.
Cogan JD, Pauciulo MW, Batchman AP, Prince MA, Robbins IM, Hedges LK, Stanton KC, Wheeler LA, Phillips JA, Loyd JE, Nichols WC. High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med [print-electronic]. 2006 Sep 9/1/2006; 174(5): 590-8. PMID: 16728714, PMCID: PMC2648061, PII: 200602-165OC, DOI: 10.1164/rccm.200602-165OC, ISSN: 1073-449X.
Willers ED, Newman JH, Loyd JE, Robbins IM, Wheeler LA, Prince MA, Stanton KC, Cogan JA, Runo JR, Byrne D, Humbert M, Simonneau G, Sztrymf B, Morse JA, Knowles JA, Roberts KE, McElroy JJ, Barst RJ, Phillips JA. Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med [print-electronic]. 2006 Apr 4/1/2006; 173(7): 798-802. PMID: 16339917, PMCID: PMC2662954, PII: 200509-1361OC, DOI: 10.1164/rccm.200509-1361OC, ISSN: 1073-449X.
Robbins IM, Kawut SM, Yung D, Reilly MP, Lloyd W, Cunningham G, Loscalzo J, Kimmel SE, Christman BW, Barst RJ. A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension. Eur. Respir. J. 2006 Mar; 27(3): 578-84. PMID: 16507859, PII: 27/3/578, DOI: 10.1183/09031936.06.00095705, ISSN: 0903-1936.
Cogan JD, Vnencak-Jones CL, Phillips JA, Lane KB, Wheeler LA, Robbins IM, Garrison G, Hedges LK, Loyd JE. Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension. Genet. Med. 2005 Mar; 7(3): 169-74. PMID: 15775752, PII: 00125817-200503000-00003, DOI: 10.109701.GIM.0000156525.09595.E9, ISSN: 1098-3600.
Robbins IM, Morrow JD, Christman BW. Oxidant stress but not thromboxane decreases with epoprostenol therapy. Free Radic. Biol. Med. 2005 Mar 3/1/2005; 38(5): 568-74. PMID: 15683712, PII: S0891-5849(04)00965-7, DOI: 10.1016/j.freeradbiomed.2004.11.033, ISSN: 0891-5849.
Kuhn KP, Wickersham NE, Robbins IM, Byrne DW. Acute effects of sildenafil in patients with primary pulmonary hypertension receiving epoprostenol. Exp. Lung Res. 2004 Mar; 30(2): 135-45. PMID: 14972773, PII: J2WM7MFN21M0V50L, ISSN: 0190-2148.
Runo JR, Welch DC, Ness EM, Robbins IM, Milstone AP. Miliary tuberculosis as a cause of acute empyema. Respiration. 2003 Sep; 70(5): 529-32. PMID: 14665781, PII: 74213, DOI: 74213, ISSN: 0025-7931.
Runo JR, Vnencak-Jones CL, Prince M, Loyd JE, Wheeler L, Robbins IM, Lane KB, Newman JH, Johnson J, Nichols WC, Phillips JA. Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II. Am. J. Respir. Crit. Care Med [print-electronic]. 2003 Mar 3/15/2003; 167(6): 889-94. PMID: 12446270, PII: 200208-861OC, DOI: 10.1164/rccm.200208-861OC, ISSN: 1073-449X.
Kuhn KP, Byrne DW, Arbogast PG, Doyle TP, Loyd JE, Robbins IM. Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol. Am. J. Respir. Crit. Care Med [print-electronic]. 2003 Feb 2/15/2003; 167(4): 580-6. PMID: 12446266, PII: 200204-333OC, DOI: 10.1164/rccm.200204-333OC, ISSN: 1073-449X.
Robbins IM, Barst RJ, Rubin LJ, Gaine SP, Price PV, Morrow JD, Christman BW. Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension. Chest. 2001 Nov; 120(5): 1639-44. PMID: 11713147, PII: S0012-3692(15)36373-X, ISSN: 0012-3692.
Doyle TP, Loyd JE, Robbins IM. Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis. Am. J. Respir. Crit. Care Med. 2001 Aug 8/15/2001; 164(4): 657-60. PMID: 11520733, DOI: 10.1164/ajrccm.164.4.2012132, ISSN: 1073-449X.
Holcomb BW, Loyd JE, Byrd BF, Wilsdorf TT, Casey-Cato T, Mason WR, Robbins IM. Iatrogenic paradoxical air embolism in pulmonary hypertension. Chest. 2001 May; 119(5): 1602-5. PMID: 11348976, PII: S0012-3692(15)39629-X, ISSN: 0012-3692.
Holcomb BW, Loyd JE, Ely EW, Johnson J, Robbins IM. Pulmonary veno-occlusive disease: a case series and new observations. Chest. 2000 Dec; 118(6): 1671-9. PMID: 11115457, PII: S0012-3692(15)37877-6, ISSN: 0012-3692.
Sadikot RT, Robbins IM. An interesting electrolyte problem. Postgrad Med J. 2000 Jul; 76(897): 435, 447-8. PMID: 10878216, PMCID: PMC1741634, ISSN: 0032-5473.
Robbins IM, Gaine SP, Schilz R, Tapson VF, Rubin LJ, Loyd JE. Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus. Chest. 2000 Jan; 117(1): 14-8. PMID: 10631192, PII: S0012-3692(15)30922-3, ISSN: 0012-3692.
Robbins IM, Christman BW, Newman JH, Matlock R, Loyd JE. A survey of diagnostic practices and the use of epoprostenol in patients with primary pulmonary hypertension. Chest. 1998 Nov; 114(5): 1269-75. PMID: 9824000, PII: S0012-3692(16)33059-8, ISSN: 0012-3692.
Robbins IM, Colvin EV, Doyle TP, Kemp WE, Loyd JE, McMahon WS, Kay GN. Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation. 1998 Oct 10/27/1998; 98(17): 1769-75. PMID: 9788832, ISSN: 0009-7322.
Robbins IM, Cuiper LL, Stein CM, Wood AJ, He HB, Parker R, Christman BW. Angiotensin II mediates systemic rebound hypertension after cessation of prostacyclin infusion in sheep. J. Appl. Physiol. 1998 Aug; 85(2): 731-7. PMID: 9688753, ISSN: 8750-7587.